Oura, the Finnish brand of smart rings, planned to go public on the Nasdaq on September 30 in an offering that could value the company at more than $15 billion. However, on September 29, just hours before pricing, the company postponed the IPO, citing uncertainty in the market. According to Reuters, the company has not announced a new date. The plan, and the pause, says as much about the financial market, as it does about the way people consume technology nowadays.
The Initial Public Offering (IPO), shows that wellness – a lifestyle built around tracking sleep, stress, and self-improvement – has already become a major business, driven by a constant search for self-knowledge and, in Oura’s case, by subscriptions as well. But, along with the promise of tailored health, comes an uncomfortable question: What are people giving up, in terms of intimate information, in exchange for a better understanding of their own bodies?
From Wrist to Finger, Wellness Finds a New Place
To better understand how and why a ring, that appears to be simple at first glance, is now successful, it is worth comparing it with popular smartwatches. Apple, Samsung, Garmin and Fitbit are examples of brands that sell watches with digital screens and notifications. Unlike these devices, the Oura ring emphasizes its design: It looks like a piece of jewelry, without the screens to distract the user and, also, easily forgotten on its finger – which is important, given the fact that the most valuable data is collected while the user sleeps.
However, a comparison of eight smart rings by the German website Netzwelt, concluded that the smartwatch remains the best choice for fitness-conscious consumers. Ahead of that, why are sales figures for wellness rings on the rise?
The answer may lie in society’s consumption habits. Perhaps, when a consumer product emerges and people begin to use and spread the word about it, it can become a sought-after item precisely, since it is different, compared to what already exists – in this case, the smartwatches. Eventually, it may be replaced by a new product, which offers those same features.
The interest in Oura’s planned IPO points in the same direction when it comes to society consumption habits. Reports said the offering drew about four times more orders than shares available, suggesting that monitoring the body is now seen as a serious business, not a passing trend.
Still, a researcher at IPOX told Reuters that demand was reasonable, but not overwhelming for a well-known consumer brand. In other words, people are willing to pay to understand their bodies better, and investors are willing to bet on it – although that enthusiasm has limits.
As a result, devices like the Oura Ring are emerging all over the world – Samsung’s Galaxy Ring, Ultrahuman’s Ring Air, RingConn, and Amazefit’s Helio Ring. These companies increasingly compete with one another, since they are shaped by consumer demand. For example, Samsung – who sells both smart watches and rings – puts two items of their brand in a competition among consumers for attention and spending.
The Data Record Behind Every Score
The appeal lies in the sheer amount of information that such a small device is able to capture. Oura’s own documents mention more than 50 metrics, documented in an app, where the data is translated into scores, followed by AI recommendations. For the company, this continuous stream of information is one of its most valuable assets and the foundation of its partnerships with researchers and healthcare professionals.
Another question that comes up, when speaking about the Oura Ring, is the confidence of customers to share their data, without the knowledge of where or who will receive them.
For many users, the trade-off might seem worth it. In return, they receive something that feels personal and practical: numbers that explains why they felt so exhausted on a certain day or even an excuse to go to bed early. In a world where health advice often feels vague, this score can provide a sense of clarity for fitness enthusiasts.
The Price We Pay For Answers
This is where the downsides begin. Health data collected by trackers may not be covered by the same privacy protections applied to information shared with doctors and hospitals, leaving much of the responsibility of protecting data to company policies and user consent.
Also, the ceaseless need to track numbers, may result in mental issues. Researchers use the term “Orthosomnia” to describe people who become anxious about their sleep scores and for whom the act of monitoring itself actually worsens their rest. Coined in a 2017 study, the term points to a wider side effect of the wellness lifestyle: when sleep, stress and recovery become numbers to improve, rest turns into one more thing to optimize.
That pressure has given rise to a countermovement, known as the over-optimization backlash or anti-optimization wellness, which the Global Wellness summit named one of its defining trends of 2026, describing a shift away from treating the body as “a system to hack rather than a state to inhabit”. The tension is hard for the industry to ignore because, the optimization culture people are pushing back against, is also what keeps the business growing – with every score inviting another adjustment, another metric, and another reason to stay subscribed..
A ring that costs about $400, plus a subscription fee, is also considered a status symbol– and the numbers show how that appeal translates into growth. Oura’s revenue rose about 74%, to $1.21 billion, in nine months, and the company expects to end 2026 with about 5.7 million paying subscribers. With the subscription, every ring sold turns into a recurring source of income, explaining why investors value the company at over $1.1 billion.
Oura Waits for the Right Moment
So why did Oura step back? The company blamed market uncertainty, a period in which, according to the portal Exame, the U.S. IPO market lost steam as investors questioned heavy spending on AI and high valuations, while rising bond yields and fears of new interest rate hikes added to the pressure. IFR also highlights valuation as a factor, reporting that the disagreement centered on how much investors were willing to pay based on Oura’s projected growth.
As for what comes next, there isn’t any new date. Even though the CEO, Tom Hale, said that the company has the luxury of choosing their own moment. Oura says it is profitable and expects revenue to grow 90% this fiscal year, so the IPO is delayed, not abandoned. The ring, in the meantime, stays on millions of fingers.
————————————————–
The article above was edited by Júlia Festagallo.
Liked this type of content? Check Her Campus Cásper Líbero home page for more!